Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8VRR

4H11-scFv antibody

Summary for 8VRR
Entry DOI10.2210/pdb8vrr/pdb
Related8VRS
Descriptor4H11 scFv chain (2 entities in total)
Functional Keywordssingle-chain antibody humanized nanobody, peptide binding protein, immune system
Biological sourceMus musculus
Total number of polymer chains1
Total formula weight27449.22
Authors
Lee, K.,Perry, K.,Yeku, O.O.,Spriggs, D.R. (deposition date: 2024-01-22, release date: 2024-04-03, Last modification date: 2024-11-13)
Primary citationLee, K.,Perry, K.,Xu, M.,Veillard, I.,Kumar, R.,Rao, T.D.,Rueda, B.R.,Spriggs, D.R.,Yeku, O.O.
Structural basis for antibody recognition of the proximal MUC16 ectodomain.
J Ovarian Res, 17:41-41, 2024
Cited by
PubMed Abstract: Mucin 16 (MUC16) overexpression is linked with cancer progression, metastasis, and therapy resistance in high grade serous ovarian cancer and other malignancies. The cleavage of MUC16 forms independent bimodular fragments, the shed tandem repeat sequence which circulates as a protein bearing the ovarian cancer biomarker (CA125) and a proximal membrane-bound component which is critical in MUC16 oncogenic behavior. A humanized, high affinity antibody targeting the proximal ectodomain represents a potential therapeutic agent against MUC16 with lower antigenic potential and restricted human tissue expression.
PubMed: 38374055
DOI: 10.1186/s13048-024-01373-9
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.36 Å)
Structure validation

248636

PDB entries from 2026-02-04

PDB statisticsPDBj update infoContact PDBjnumon